Broaden newborn screening programmes | Letters

Broaden newborn screening programmes | Letters. Screening for spinal muscular atrophy is a step forward, says Dr Janet Hoskin, but what about other serious genetic conditions such as Duchenne muscular dystrophy?The decision to introduce newborn screening for spinal muscular atrophy (SMA) is a major breakthrough for families and campaigners (All newborns in England to be screened for spinal muscular atrophy from 2027, 16 July).

A apuração publicada por www.theguardian.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Screening for spinal muscular atrophy is a step forward, says Dr Janet Hoskin, but what about other serious genetic conditions such as Duchenne muscular dystrophy?The decision to introduce newborn screening for spinal muscular atrophy (SMA) is a major breakthrough for families and campaigners (All newborns in England to be screened for spinal muscular atrophy from 2027, 16 July). Early diagnosis means children can access treatment sooner, improving outcomes and giving families clarity at a crucial time.However, this success raises an important question: why are other serious genetic conditions, such as Duchenne muscular dystrophy (DMD), still excluded from newborn screening programmes?

• Ponto de atenção: broaden.
• Ponto de atenção: newborn.
• Ponto de atenção: screening.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Beleza.